MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks

Ortho market growth stable but low | Wall Street Beat

February 15, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

The market for hip and knee implants is stable but mired in a low-growth stage, according to analysts who attended the American Academy of Orthopedic Surgeons conference in San Francisco last week.

Although the abrupt departure of Stryker CEO Steve MacMillan drew the lion’s share of attention at the AAOS event, analysts from Barclays Capital and Leerink Swann agreed that the sector’s outlook calls for low-single-digit growth.

Filed Under: Funding Roundup, Mergers & Acquisitions, News Well, Orthopedics, Wall Street Beat Tagged With: Abiomed, Adocia, Asalus Medical, Athenahealth Inc., Baxter, BG Medicine Inc., BioStart, Cardinal Health, CardioComm, Cayenne Medical, Checkpoint Surgical, Cook Medical, Cutera Inc., Cynosure Inc., Daxor Corp., Deals Roundup, Delcath Systems Inc., Dentsply Sirona, Dexcom, dextera, EDAP TMS SA, Edwards Lifesciences, Eos Imaging, Focus Product Development, GE Healthcare, Halt Medical, Hillrom, Hospira Inc., Insulet, Iridex Corp., Medisafe Technologies Corp., Merit Medical Systems, NovaRay Medical, Organovo, Ostial Solutions, PositiveID Corp., Rockwell Medical Technologies, Secure eHealth, Smith & Nephew, SOLOS Endoscopy Inc., Solta Medical Inc., Syneron Medical Ltd., Synovis Life Technologies Inc., tandemdiabetes, titanmedical, Toshiba, Volker Group, Wound Management Technologies

Cordis to distribute Ostial Solutions stent positioning system

December 1, 2010 By MassDevice staff Leave a Comment

Cordis, Ostial logos

Cordis Corp., the stent-making division of Johnson & Johnson (NYSE:JNJ) inked a worldwide distribution deal with Ostial Solutions for a stent-positioning system designed to treat aorto-ostial blockages.

Kalamazoo, Mich.-based Ostial makes the Ostial Pro stent positioning system, which it sells in the U.S. Under the terms of the deal with Bridgewater, N.J.-based Cordis, the J&J subsidiary plans to roll the system out worldwide during the first half of 2011.

Filed Under: Business/Financial News, News Well, Stents Tagged With: Cordis Corp., Ostial Solutions

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS